CITIUS ONCOLOGY, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Citius Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2023 to Q2 2025.
  • Citius Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $2.13M, a 8.6% increase year-over-year.
  • Citius Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $7.69M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $7.69M $2.13M +$168K +8.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $7.52M $2.09M +$132K +6.72% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $7.39M $1.81M -$109K -5.66% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-14
Q3 2024 $7.5M $1.67M Jul 1, 2024 Sep 30, 2024 10-K 2024-12-27
Q2 2024 $1.96M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $1.96M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 $1.92M Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.